Based on mRNA analysis of a set of classic Wnt targets and detection of nuclear β-catenin protein levels in cancer tissues, β-catenin signaling is elevated in ligand-independent CRC samples that had either APC or CTNNB1 mutations, (28, 29). The gene discussed is APC; the disease is cancer.